QUADRANT DRY COW INTRAMAMMARY ANTIBIOTIC

País: Austrália

Língua: inglês

Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes ativos:

CEPHALONIUM DIHYDRATE

Disponível em:

VIRBAC (AUSTRALIA) PTY LTD

DCI (Denominação Comum Internacional):

cephalonium dihydrate(89.9g/kg)

Forma farmacêutica:

MISC. INTRA MAMMARY

Composição:

CEPHALONIUM DIHYDRATE ANTIBIOTIC Active 89.9 g/kg

Unidades em pacote:

#120; #syringes; %200; %syringes; &800; &syringes; *40; *syringes; @20; @syringes; ^400; ^syringes

Classe:

VM - Veterinary Medicine

Grupo terapêutico:

DAIRY CATTLE - NON-LACTATING (DRY) PERIO

Área terapêutica:

ANTIBIOTIC & RELATED

Indicações terapêuticas:

BACTERIA

Resumo do produto:

Poison schedule: 4; Withholding period: WHP: MEAT: DO NOT USE less than 21 day s before slaughter for human consumptio n MILK: DO NOT USE in lactating cows or within 49 days of calving. Colostrum o r milk collected from treated cows with in 96 hours (8 milkings) of calving MUS T NOT BE USED for human consumption or processing. If calving occurs earlier than 49 days after treatment milk may contain residues. Milk collected from t reated cows with 49 days plus 96 hours (8 milkings) after treatment MUST NOT B E USED for human consumption or supplie d for processing. Calves fed this milk should not be slaughtered for human co nsumption for 21 days. TRADE ADVICE: Export Slaughter Interval (ESI): DO NOT USE less than 21 days before slaug hter for export. DO NOT USE less than 2 1 days before slaughter for export. Befo re using this product confirm the curren t ESI from Virbac on 1800 242 100 or the APVMA website (www.apvma.gov.au/residue s); Host/pest details: DAIRY CATTLE - NON-LACTATING (DRY) PERIO: [BACTERIA]; For sustained, broad spectrum control of & protection against mastitis-causing bacteria (incl. penicillin-resistant strains) in non-lactating dairy cattle.Use only at the time of drying off. Do not use on lactating cows or cows with a dry period of less than 49 days. See also WITHHOLDING PERIODS & TRADE ADVICE sections on label.

Status de autorização:

Registered

Data de autorização:

2023-07-01

Folheto informativo - Bula

VIRBAC (AUSTRALIA) PTY LIMITED
Page
1
of 3
PRODUCT NAME:
QUADRANT
®
DRY COW INTRAMAMMARY ANTIBIOTIC
APVMA NUMBER:
65805 / 111069
VERSION DATE:
06 July 2017
PACK SIZES:
3 g Syringe; 20 x 3 g Syringes; 40 x 3 g Syringes; 120 x 3 g Syringes;
200 x 3 g
Syringes; 400 x 3 g Syringes; 800 x 3 g Syringes;
Signal heading:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Product name:
QUADRANT
® DRY COW INTRAMAMMARY ANTIBIOTIC
Active constituent/s:
89.9 G/KG CEPHALONIUM DIHYDRATE
Statement of
claims:
For sustained, broad spectrum control of and protection against
mastitis-causing
bacteria (including penicillin-resistant strains) in non-lactating
dairy cattle.
Cephalonium is active against: _Staphylococcus aureus_, including
penicillin
resistant strains, _Streptococcus agalactiae_, _Streptococcus
dysgalactiae_,
_Streptococcus uberis, Escherichia coli, Corynebacterium pyogenes _and
_Corynebacterium ulcerans_. The antibiotic is also active against
other organisms
recovered from the bovine udder, including _Proteus_ spp.,
_Klebisella_ spp.,
_Citrobacter_ spp. and Enterobacter strains.
Net contents:
3 g Syringe; 20 x 3 g Syringes; 40 x 3 g Syringes; 120 x 3 g Syringes;
200 x 3 g Syringes;
400 x 3 g Syringes; 800 x 3 g Syringes;
Directions for Use
Heading:
DIRECTIONS FOR USE:
Restraints:
DO NOT USE IN LACTATING COWS
DO NOT USE IN COWS WITHIN 49 DAYS OF CALVING. IF ACCIDENTALLY
ADMINISTERED
TO A LACTATING ANIMAL OR WITHIN 49 DAYS OF CALVING, CONTACT THE
PRESCRIBING
VETERINARIAN FOR ADVICE.
Contraindications:
Precautions:
Side effects:
Dosage &
administration:
Use QUADRANT DRY COW as directed by your Veterinarian as part of a
mastitis
control program.
The contents of one syringe should be infused into the teat canal of
each quarter
immediately after the last milking of the lactation. Before infusion,
the teat should
be
thoroughly
cleaned
and
disinfected.
Care
should
be
taken
to
avoid
contamination of the syringe nozzle after the protective cap has been
removed.
Partially insert nozzle and infuse